Neurodegenerative diseases and neuropsychiatric disorders
Conditions
Interventions
None listed
Sponsors
National Institutes for Quantum Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects who underwent MRI or MRI and PET scans in existing studies conducted by QST targeting healthy individuals and those with neurodegenerative and psychiatric disorders.
Exclusion criteria
Exclusion criteria: 1)Cases where the research subject or their representative refused to allow their data to be used for secondary research when the existing research was explained. 2)Cases where the research subject or their representative refused to allow their data to be used for this research when information about this research was disclosed. 3)Cases where there was missing data that affected data analysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant differences in MRI markers (quantitative values) related to brain microstructure, brain deposits, and brain function between patients with each disease and healthy controls | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation between each MRI marker and PET accumulation, blood biomarkers, neuropsychological tests, and clinical symptoms | — |
Countries
Japan
Contacts
Public ContactMARI MIYATA
National Institutes for Quantum Science and Technology Advanced Neuroimaging Center
Outcome results
None listed